{"id":"https://openalex.org/W3081886009","doi":"https://doi.org/10.1158/1538-7445.am2020-1048","title":"Abstract 1048: Genomic analysis of patients with relapsed ovarian cancer enrolled in a phase II trial of nivolumab and bevacizumab","display_name":"Abstract 1048: Genomic analysis of patients with relapsed ovarian cancer enrolled in a phase II trial of nivolumab and bevacizumab","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3081886009","doi":"https://doi.org/10.1158/1538-7445.am2020-1048","mag":"3081886009"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-1048","doi":"https://doi.org/10.1158/1538-7445.am2020-1048","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1048","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062818691","display_name":"Elizabeth H. Stover","orcid":"https://orcid.org/0000-0002-6578-3216","observed_orcids":["https://orcid.org/0000-0002-6578-3216"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth H. Stover","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010499534","display_name":"Svitlana Tyekucheva","orcid":"https://orcid.org/0000-0002-3119-6507","observed_orcids":["https://orcid.org/0000-0002-3119-6507"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svitlana Tyekucheva","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100770939","display_name":"Yiwen Liu","orcid":"https://orcid.org/0000-0003-0455-1013","observed_orcids":["https://orcid.org/0000-0003-0455-1013"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yiwen Liu","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003082405","display_name":"Jennifer D. Curtis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer D. Curtis","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089955620","display_name":"Richard T. Penson","orcid":"https://orcid.org/0000-0002-8091-8588","observed_orcids":["https://orcid.org/0000-0002-8091-8588"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard T. Penson","raw_affiliation_strings":["2Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060953135","display_name":"Joyce F. Liu","orcid":"https://orcid.org/0000-0003-3888-3972","observed_orcids":["https://orcid.org/0000-0003-3888-3972"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce F. Liu","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"1048","last_page":"1048"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6970000267028809},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7850000262260437},{"id":"https://openalex.org/keywords/tumor-genomic-alterations","display_name":"tumor genomic alterations","score":0.7549999952316284},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/myc-amplification","display_name":"MYC amplification","score":0.9110000133514404},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.9100000262260437},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mutational-signatures","display_name":"mutational signatures","score":0.796999990940094},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.9330000281333923},{"id":"https://openalex.org/keywords/long-term-responders","display_name":"long-term responders","score":0.6600000262260437},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8197596669197083},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8041209578514099},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6414300203323364},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6171388626098633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6003434658050537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5120771527290344},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4604656398296356},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.45180973410606384},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.4219599962234497},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.36646705865859985},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3509158492088318},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24181115627288818},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22932496666908264},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20416474342346191},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.12276473641395569},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.11723092198371887},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0960371196269989}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-1048","doi":"https://doi.org/10.1158/1538-7445.am2020-1048","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-1048","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2947762586","https://openalex.org/W2396047583","https://openalex.org/W2886065420","https://openalex.org/W7202180119","https://openalex.org/W1922456582","https://openalex.org/W4406271606","https://openalex.org/W2016473936","https://openalex.org/W3112494928","https://openalex.org/W2954452700","https://openalex.org/W3197410476"],"abstract_inverted_index":{"Abstract":[0],"We":[1,104],"analyzed":[2],"genomic":[3,84,107,242,265,297],"alterations":[4,108,128,143,213,221,231,266],"in":[5,17,23,83,109,129,147,159,175,184,236,274,309,339],"patients":[6,32,111,188,248,273,333],"with":[7,12,35,113,121,169,218,249,255,334],"relapsed":[8,250,335],"ovarian":[9,148,251,310,336],"cancer":[10,252,337],"treated":[11,34,112],"combined":[13],"nivolumab":[14,36,114,256,345],"and":[15,37,39,69,76,115,141,226,232,257,271,306,346,366],"bevacizumab":[16,38,347],"a":[18,177,288,340],"phase":[19,341],"II":[20,342],"clinical":[21,102,190],"trial,":[22],"order":[24],"to":[25,278,295,303],"identify":[26,264,296],"potential":[27],"biomarkers":[28,300],"of":[29,71,98,136,153,161,173,187,229,247,281,301,332,344,351,355],"response.":[30],"Thirty-eight":[31],"were":[33,87,164,181],"the":[40,106,130,151,170,185,223,275,352,356],"previously":[41],"reported":[42],"overall":[43],"response":[44,90,100,167,224],"rate":[45,194],"was":[46,195,202],"28.9%":[47],"(Liu":[48],"et":[49],"al,":[50],"JAMA":[51],"Oncology,":[52],"2019).":[53],"Formalin-fixed":[54],"paraffin-embedded":[55],"patient":[56,131],"tumor":[57],"samples":[58],"(acquired":[59],"pre-treatment)":[60],"underwent":[61],"whole-exome":[62],"sequencing,":[63],"followed":[64],"by":[65,94],"quality":[66],"control":[67],"filtering":[68],"analysis":[70,210,244,331],"mutations,":[72],"insertions/deletions,":[73],"copy-number":[74,142,212,220,230],"alterations,":[75],"mutational":[77,200,233],"signatures":[78,234],"using":[79],"established":[80],"methods.":[81],"Differences":[82],"event":[85],"rates":[86],"assessed":[88],"between":[89,166,197,206,222],"groups,":[91,168,225],"as":[92,287],"defined":[93],"presence":[95],"or":[96,101,298],"absence":[97],"objective":[99],"benefit.":[103,191],"describe":[105,241],"all":[110],"bevacizumab,":[116],"including":[117],"several":[118],"long-term":[119],"responders":[120],"treatment":[122,254],"duration":[123],">24":[124],"months.":[125],"The":[126],"observed":[127,165],"cohort":[132],"reflected":[133],"known":[134],"patterns":[135],"common":[137],"mutations":[138,163,174],"(e.g.":[139,144],"TP53)":[140],"MYC":[145],"amplification)":[146],"cancer.":[149,311],"Within":[150],"limits":[152],"sample":[154],"size,":[155],"no":[156],"significant":[157],"differences":[158],"frequency":[160],"specific":[162],"possible":[171],"exception":[172],"SETD1B,":[176],"histone":[178],"methyltransferase,":[179],"which":[180],"more":[182],"frequent":[183],"subset":[186],"lacking":[189],"BRCA1/2":[192],"mutation":[193],"similar":[196],"groups.":[198,207],"Tumor":[199],"burden":[201],"not":[203,215,263],"significantly":[204],"different":[205],"Initial":[208],"exploratory":[209],"for":[211,359],"did":[214,262],"reveal":[216],"genes":[217],"differential":[219],"further":[227],"analyses":[228],"are":[235,293],"progress.":[237],"In":[238],"summary,":[239],"we":[240,261],"biomarker":[243],"from":[245],"tumors":[246],"receiving":[253],"bevacizumab.":[258],"Taken":[259],"together,":[260],"that":[267],"clearly":[268],"distinguish":[269],"responding":[270],"non-responding":[272],"data":[276,284],"evaluated":[277],"date.":[279],"Analysis":[280],"targeted":[282],"RNA-sequencing":[283],"is":[285],"planned":[286],"next":[289],"step.":[290],"Further":[291],"studies":[292],"needed":[294],"transcriptomic":[299],"responses":[302],"checkpoint":[304],"blockade":[305],"anti-angiogenic":[307],"therapy":[308],"Citation":[312],"Format:":[313],"Elizabeth":[314],"H.":[315],"Stover,":[316],"Svitlana":[317],"Tyekucheva,":[318],"Yiwen":[319],"Liu,":[320],"Jennifer":[321],"D.":[322],"Curtis,":[323],"Richard":[324],"T.":[325],"Penson,":[326],"Joyce":[327],"F.":[328],"Liu.":[329],"Genomic":[330],"enrolled":[338],"trial":[343],"[abstract].":[348],"In:":[349],"Proceedings":[350],"Annual":[353],"Meeting":[354],"American":[357],"Association":[358],"Cancer":[360,372],"Research":[361],"2020;":[362],"2020":[363],"Apr":[364],"27-28":[365],"Jun":[367],"22-24.":[368],"Philadelphia":[369],"(PA):":[370],"AACR;":[371],"Res":[373],"2020;80(16":[374],"Suppl):Abstract":[375],"nr":[376],"1048.":[377]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2020-09-08T00:00:00"}